Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

OptimizeRx (OPRX) Tax Provisions (2023 - 2026)

OptimizeRx's Tax Provisions history spans 3 years, with the latest figure at $2.5 million for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 7.22% to $2.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 150.62% increase, with the full-year FY2025 number at $1.8 million, up 150.76% from a year prior.
  • Tax Provisions hit $2.5 million in Q4 2025 for OptimizeRx, up from $270000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for OPRX hit a ceiling of $2.5 million in Q4 2025 and a floor of -$1.1 million in Q2 2024.
  • Historically, Tax Provisions has averaged $286111.1 across 3 years, with a median of $181000.0 in 2025.
  • Biggest five-year swings in Tax Provisions: tumbled 3396.97% in 2024 and later skyrocketed 133.05% in 2025.
  • Tracing OPRX's Tax Provisions over 3 years: stood at $33000.0 in 2023, then soared by 6827.27% to $2.3 million in 2024, then rose by 7.22% to $2.5 million in 2025.
  • Business Quant data shows Tax Provisions for OPRX at $2.5 million in Q4 2025, $270000.0 in Q3 2025, and $181000.0 in Q2 2025.